Debra Ellies
Chief Executive Officer at OssiFi
- Role
- Member Board of Trustees at MRIGlobal
- Location
- Overland Park, KS, US
- LinkedIn followers
- 500 followers
About Debra Ellies
At OssiFi, my leadership for over 18 years has been instrumental in advancing innovative therapies for bone regenerative medicine. We have pioneered first-in-class inhibitors targeting sclerostin, significantly impacting treatments for conditions like Osteogenesis Imperfecta, Osteoporosis fractures, and spinal fusion. My Post Doctoral team\'s collaborative efforts led to the development of Sclerostin-blocking antibodies, culminating in the FDA\'s approval of a groundbreaking therapy, Evenity, for osteoporotic women at high fracture risk.My role extends beyond the lab, as a trustee at MRIGlobal, where we focus on global scientific research initiatives. With a solid foundation in molecular embryology and anatomy, I leverage my biotechnology and life sciences expertise to steer strategic decisions and foster an environment where scientific discovery and patient welfare are paramount. My commitment to innovation is matched by a dedication to public education, particularly in preventive measures against esophageal cancer.
Experience
Member Board of Trustees
Jan 2016 — Present · Kansas City, MO, US
Education
University of Ottawa
MSc, Molecular embryology / anatomy
1994 — 1996
King's College London
PhD, Developmental Neurobiology
1996 — 1999
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.